Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
291
Price
$63.00
Total Value
$18.33K
Shares Held After
450,335
% of Holdings
0.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bhatia Sangeeta N. — Director
Shares
266
Price
$500.00
Total Value
$133.00K
Shares Held After
4,299
% of Holdings
5.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
988
Price
$499.00
Total Value
$493.01K
Shares Held After
16,838
% of Holdings
5.5%
Vir Biotechnology, Inc. (VIR)
Sabatini Brent — SVP, Chief Accounting Officer
Shares
1,530
Price
$7.79
Total Value
$11.92K
Shares Held After
47,872
% of Holdings
3.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
1,959
Price
$310.08
Total Value
$607.45K
Shares Held After
23,305
% of Holdings
7.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
2,242
Price
$310.08
Total Value
$695.20K
Shares Held After
59,802
% of Holdings
3.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
1,959
Price
$310.08
Total Value
$607.45K
Shares Held After
31,769
% of Holdings
5.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
6,958
Price
$310.08
Total Value
$2.16M
Shares Held After
85,662
% of Holdings
7.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
2,242
Price
$310.08
Total Value
$695.20K
Shares Held After
24,848
% of Holdings
8.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$102.09
Total Value
$204.18K
Shares Held After
0
% of Holdings
100.0%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
10,000
Price
$5.81
Total Value
$58.14K
Shares Held After
204,657
% of Holdings
4.7%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$27.58
Total Value
$175.10K
Shares Held After
44,089
% of Holdings
12.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
4,166
Price
$27.33
Total Value
$113.86K
Shares Held After
50,437
% of Holdings
7.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
3,541
Price
$27.33
Total Value
$96.78K
Shares Held After
50,437
% of Holdings
6.6%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
6,207
Price
$82.07
Total Value
$509.40K
Shares Held After
32,105
% of Holdings
16.2%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
9,435
Price
$81.56
Total Value
$769.51K
Shares Held After
38,312
% of Holdings
19.8%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
4,160
Price
$26.36
Total Value
$109.66K
Shares Held After
19,860
% of Holdings
20.9%
OCULAR THERAPEUTIX, INC (OCUL)
Nayak Sanjay — Chief Strategy Officer
Shares
10,348
Price
$9.04
Total Value
$93.55K
Shares Held After
332,412
% of Holdings
3.0%
OCULAR THERAPEUTIX, INC (OCUL)
Dugel Pravin — Director
Shares
124,882
Price
$9.04
Total Value
$1.13M
Shares Held After
3,033,078
% of Holdings
4.0%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
11,446
Price
$9.04
Total Value
$103.47K
Shares Held After
366,356
% of Holdings
3.0%
OCULAR THERAPEUTIX, INC (OCUL)
Waheed Nadia — Chief Medical Officer
Shares
7,863
Price
$9.04
Total Value
$71.08K
Shares Held After
318,417
% of Holdings
2.4%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
90,000
Price
$5.23
Total Value
$470.99K
Shares Held After
214,657
% of Holdings
29.5%
Entera Bio Ltd. (ENTX)
Rubin Steven D — Director
Shares
5,000
Price
$1.49
Total Value
$7.45K
Shares Held After
15,000
% of Holdings
33.3%
ZIVO Bioscience, Inc. (ZIVO)
STROME MARK E — 10% Owner
Shares
20,000
Price
$9.77
Total Value
$195.40K
Shares Held After
472,942
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Palisade Bio, Inc. (PALI)
Finley John David — Director
Shares
3,896
Price
$1.75
Total Value
$6.82K
Shares Held After
27,353
% of Holdings
12.5%
Palisade Bio, Inc. (PALI)
Jones Mitchell Lawrence — Chief Medical Officer
Shares
1,989
Price
$1.75
Total Value
$3.48K
Shares Held After
13,263
% of Holdings
13.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
521
Price
$29.64
Total Value
$15.44K
Shares Held After
50,437
% of Holdings
1.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
5,828
Price
$28.94
Total Value
$168.63K
Shares Held After
50,958
% of Holdings
10.3%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,000
Price
$26.50
Total Value
$132.50K
Shares Held After
15,700
% of Holdings
31.8%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,700
Price
$24.34
Total Value
$138.74K
Shares Held After
10,700
% of Holdings
53.3%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,000
Price
$23.77
Total Value
$118.85K
Shares Held After
5,000
% of Holdings
100.0%
Tyra Biosciences, Inc. (TYRA)
Bensen Daniel — Chief Discovery Officer
Shares
5,872
Price
$33.37
Total Value
$195.93K
Shares Held After
146,981
% of Holdings
3.8%
Tyra Biosciences, Inc. (TYRA)
Bensen Daniel — Chief Discovery Officer
Shares
2,128
Price
$31.50
Total Value
$67.04K
Shares Held After
152,853
% of Holdings
1.4%
Neuraxis, INC (NRXS)
Hannasch Brian — 10% Owner
Shares
40,000
Price
$4.92
Total Value
$196.80K
Shares Held After
1,211,522
% of Holdings
3.3%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
3,354
Price
$15.70
Total Value
$52.66K
Shares Held After
428,286
% of Holdings
0.8%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
546
Price
$23.86
Total Value
$13.03K
Shares Held After
651,112
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
547
Price
$23.86
Total Value
$13.05K
Shares Held After
651,114
% of Holdings
0.1%
ONCOLYTICS BIOTECH INC (ONCY)
Andrews Patricia S — Director
Shares
35,400
Price
$0.86
Total Value
$30.29K
Shares Held After
78,128
% of Holdings
45.3%
Showing 501–550 of 936 transactions (page 11 of 19)